{"organizations": [], "uuid": "99f7eccacf76c364eedb50f4fd56f9781e710c3e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/bayer-agm/bayer-cuts-monsanto-synergy-target-to-1-2-bln-due-to-divestments-idUSF9N1SA02K", "country": "US", "domain_rank": 408, "title": "Bayer cuts Monsanto synergy target to $1.2 bln due to divestments", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-25T11:14:00.000+03:00", "replies_count": 0, "uuid": "99f7eccacf76c364eedb50f4fd56f9781e710c3e"}, "author": "", "url": "https://www.reuters.com/article/bayer-agm/bayer-cuts-monsanto-synergy-target-to-1-2-bln-due-to-divestments-idUSF9N1SA02K", "ord_in_thread": 0, "title": "Bayer cuts Monsanto synergy target to $1.2 bln due to divestments", "locations": [], "entities": {"persons": [{"name": "patricia weiss", "sentiment": "none"}, {"name": "ludwig burger", "sentiment": "none"}, {"name": "werner baumann", "sentiment": "none"}], "locations": [{"name": "bonn", "sentiment": "none"}], "organizations": [{"name": "monsanto", "sentiment": "negative"}, {"name": "bayer", "sentiment": "negative"}, {"name": "ebitda", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 25, 2018 / 8:17 AM / Updated 6 minutes ago Bayer cuts Monsanto synergy target to $1.2 bln due to divestments Reuters Staff 1 Min Read\nBONN, May 25 (Reuters) - Bayer said that combining with takeover target Monsanto will have positive synergy effects of about $1.2 billion on core earnings, less than the $1.5 billion initially targeted because more divestments were needed to get antitrust approval.\nThe German drugs and pesticides maker, which is holding its annual shareholder meeting on Friday, said in a statement that the targeted synergies will have their full effect on annual adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) from 2022.\nBayer Chief Executive Werner Baumann said he expects the transaction to be closed in the near future. (Reporting by Patricia Weiss Writing by Ludwig Burger)", "external_links": [], "published": "2018-05-25T11:14:00.000+03:00", "crawled": "2018-05-25T11:38:00.005+03:00", "highlightTitle": ""}